Website intended for a NZ health professional readership
This article looks at the benefits and risks of a gluten-free diet for those with coeliac disease, irritable bowel syndrome, non-coeliac gluten sensitivity and other conditions
1. Melini V, Melini F. Gluten-free diet: Gaps and needs for a healthier diet. Nutrients 2019;11(1):170.
2. Hellman R. Gluten free diets - A challenge for the practicing physician. Mo Med 2020;117(2):119–23.
3. Nordin E, Brunius C, Landberg R, Hellström PM. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. Am J Clin Nutr 2022;115(2):344–52.
4. Biesiekierski JR, Iven J. Non-coeliac gluten sensitivity: piecing the puzzle together. United European Gastroenterol J 2015;3(2):160–65.
5. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145(2):320–28.e1–3.
6. Skodje GI, Sarna VK, Minelle IH, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018;154(3):529–39.e2.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
